Development of a Comprehensive Open Access "molecules with Androgenic Activity Resource (MAAR)" to Facilitate Risk Assessment of Chemicals

Overview

Journal Exp Biol Med (Maywood)

Specialty Biology

Date 2024 Oct 4

PMID 39364092

Authors

Fan Dong

Barry Hardy

Jie Liu

Tomaz Mohoric

Wenjing Guo

Thomas Exner

Weida Tong

Joh Dohler

Daniel Bachler

Huixiao Hong

Affiliations

Soon will be listed here.

Abstract

The increasing prevalence of endocrine-disrupting chemicals (EDCs) and their potential adverse effects on human health underscore the necessity for robust tools to assess and manage associated risks. The androgen receptor (AR) is a critical component of the endocrine system, playing a pivotal role in mediating the biological effects of androgens, which are male sex hormones. Exposure to androgen-disrupting chemicals during critical periods of development, such as fetal development or puberty, may result in adverse effects on reproductive health, including altered sexual differentiation, impaired fertility, and an increased risk of reproductive disorders. Therefore, androgenic activity data is critical for chemical risk assessment. A large amount of androgenic data has been generated using various experimental protocols. Moreover, the data are reported in different formats and in diverse sources. To facilitate utilization of androgenic activity data in chemical risk assessment, the Molecules with Androgenic Activity Resource (MAAR) was developed. MAAR is the first open-access platform designed to streamline and enhance the risk assessment of chemicals with androgenic activity. MAAR's development involved the integration of diverse data sources, including data from public databases and mining literature, to establish a reliable and versatile repository. The platform employs a user-friendly interface, enabling efficient navigation and extraction of pertinent information. MAAR is poised to advance chemical risk assessment by offering unprecedented access to information crucial for evaluating the androgenic potential of a wide array of chemicals. The open-access nature of MAAR promotes transparency and collaboration, fostering a collective effort to address the challenges posed by androgenic EDCs.

References

Fourches D, Muratov E, Tropsha A . Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J Chem Inf Model. 2010; 50(7):1189-204. PMC: 2989419. DOI: 10.1021/ci100176x. View

Sakkiah S, Ng H, Tong W, Hong H . Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discovery. Expert Opin Ther Targets. 2016; 20(10):1267-82. DOI: 10.1080/14728222.2016.1192131. View

Liu J, Xu L, Guo W, Li Z, Khan M, Ge W . Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment. Exp Biol Med (Maywood). 2023; 248(21):1927-1936. PMC: 10798185. DOI: 10.1177/15353702231209413. View

Davis A, Grondin C, Johnson R, Sciaky D, Wiegers J, Wiegers T . Comparative Toxicogenomics Database (CTD): update 2021. Nucleic Acids Res. 2020; 49(D1):D1138-D1143. PMC: 7779006. DOI: 10.1093/nar/gkaa891. View

Kohonen P, Benfenati E, Bower D, Ceder R, Crump M, Cross K . The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing. Mol Inform. 2016; 32(1):47-63. DOI: 10.1002/minf.201200114. View

Shen J, Xu L, Fang H, Richard A, Bray J, Judson R . EADB: an estrogenic activity database for assessing potential endocrine activity. Toxicol Sci. 2013; 135(2):277-91. DOI: 10.1093/toxsci/kft164. View

Adebayo O, Adesanoye O, Abolaji O, Kehinde A, Adaramoye O . First-line antituberculosis drugs disrupt endocrine balance and induce ovarian and uterine oxidative stress in rats. J Basic Clin Physiol Pharmacol. 2017; 29(2):131-140. DOI: 10.1515/jbcpp-2017-0087. View

Mendez D, Gaulton A, Bento A, Chambers J, de Veij M, Felix E . ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res. 2018; 47(D1):D930-D940. PMC: 6323927. DOI: 10.1093/nar/gky1075. View

Wilkes J, Stoyanova-Slavova I, Buzatu D . Alignment-independent technique for 3D QSAR analysis. J Comput Aided Mol Des. 2016; 30(4):331-45. PMC: 4833814. DOI: 10.1007/s10822-016-9909-0. View

10.

Matsumoto T, Sakari M, Okada M, Yokoyama A, Takahashi S, Kouzmenko A . The androgen receptor in health and disease. Annu Rev Physiol. 2012; 75:201-24. DOI: 10.1146/annurev-physiol-030212-183656. View

11.

Fourches D, Muratov E, Tropsha A . Curation of chemogenomics data. Nat Chem Biol. 2015; 11(8):535. DOI: 10.1038/nchembio.1881. View

12.

Hong H, Xu L, Liu J, Jones W, Su Z, Ning B . Technical reproducibility of genotyping SNP arrays used in genome-wide association studies. PLoS One. 2012; 7(9):e44483. PMC: 3436888. DOI: 10.1371/journal.pone.0044483. View

13.

Pan B, Kusko R, Xiao W, Zheng Y, Liu Z, Xiao C . Correction to: Similarities and differences between variants called with human reference genome HG19 or HG38. BMC Bioinformatics. 2019; 20(1):252. PMC: 6521484. DOI: 10.1186/s12859-019-2776-7. View

14.

Liu T, Lin Y, Wen X, Jorissen R, Gilson M . BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res. 2006; 35(Database issue):D198-201. PMC: 1751547. DOI: 10.1093/nar/gkl999. View

15.

Ye H, Luo H, Ng H, Meehan J, Ge W, Tong W . Applying network analysis and Nebula (neighbor-edges based and unbiased leverage algorithm) to ToxCast data. Environ Int. 2016; 89-90:81-92. DOI: 10.1016/j.envint.2016.01.010. View

16.

Zhang L, Sedykh A, Tripathi A, Zhu H, Afantitis A, Mouchlis V . Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches. Toxicol Appl Pharmacol. 2013; 272(1):67-76. PMC: 3775906. DOI: 10.1016/j.taap.2013.04.032. View

17.

Hong H, Rua D, Sakkiah S, Selvaraj C, Ge W, Tong W . Consensus Modeling for Prediction of Estrogenic Activity of Ingredients Commonly Used in Sunscreen Products. Int J Environ Res Public Health. 2016; 13(10). PMC: 5086697. DOI: 10.3390/ijerph13100958. View

18.

Kavlock R, Daston G, Derosa C, Gray L, Kaattari S, Lucier G . Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect. 1996; 104 Suppl 4:715-40. PMC: 1469675. DOI: 10.1289/ehp.96104s4715. View

19.

Hong H, Tong W, Fang H, Shi L, Xie Q, Wu J . Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts. Environ Health Perspect. 2002; 110(1):29-36. PMC: 1240690. DOI: 10.1289/ehp.0211029. View

20.

Danzo B . Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ Health Perspect. 1997; 105(3):294-301. PMC: 1470005. DOI: 10.1289/ehp.97105294. View